Biotech China 2014

Oncology: Bristol-Myers Squibb

Total Score People Score Events Score
21 19 14
Date Event Presentation Speakers
February 8, 2011 Clinical Trial Forecasting, Budgeting, and Project Management TOPIC: The Fully Outsourced Model in Early Development Susan Lubin
Utilizing the "Fully Outsourced Model" for Early Development Projects Susan Lubin
September 23, 2009 Track 3: Advancing Cancer Therapy : Second Annual Translational Cancer Medicine Combination Approaches for the Treatment of Solid Tumors: Opportunities and Obstacles in the Era of Targeted Therapy Jon M Wigginton
April 7, 2009 Kinase Inhibitor Chemistry - Charting the Chemical Space Binding Modes of Fragment-Like Kinase Inhibitors Keith Constantine
January 26, 2009 Biomarker Assay Development Moving Beyond Fit-for-Purpose: Use of Lean Practices to Accelerate Biomarker Assay Development Russell S Weiner
Validation and Implementation of Flow Cytometric Assay to Evaluate Pharmacodynamic Biomarkers in Clinical Study Dianna Wu
January 26, 2009 Translational Cancer Medicine COMBINATION THERAPIES : Combination Approaches for the Treatment of Solid Tumors: Opportunities and Obstacles in the Era of Targeted Therapy Jon M Wigginton
January 26, 2009 7th Annual Partnering with Central Labs Track A : Risk Management for Global Studies Raphaële Mary
Track B : Imaging Regulatory Environment Shift Strategies Beth Sabatino
January 5, 2009 High Content Analysis Developing Enterprise-Level IT Solution to Support High-Content Screening Experiments Michael Lenard
Evaluation of High-Content Analysis Platforms to Support GPCR Screening Andrea Weston
Studying GPCR Trafficking Using Automated HCS Tools Ying Jie Zhu
November 17, 2008 BIO-Europe 2008 What Buyers Want: Understanding What Big Pharma Expect to See in Out-Licensing Documents Lubor Gaal
September 29, 2008 Genomic Biomarkers Discovery of Gene Expression-Based Pharmacodynamic Biomarkers in Tumor Immunotherapies Zenta Tsuchihashi
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Faculty Renzo Canetta, Giuseppe Giaccone, Ashok Batra
Panelists Renzo Canetta
May 30, 2008 ASCO Annual'08 Meeting clinical trials-- Choice of Comparator in Pivotal Phase III Clinical Trials: Clinical Versus Regulatory Standard of Care Steven D. Averbuch
clinical trials-- Endpoints for Immunotherapy Studies: Design and Regulatory Implications Axel Hoos
international-- Choice of Comparator in Pivotal Phase III Clinical Trials: Clinical Versus Regulatory Standard of Care Steven D. Averbuch
tumor biology-- Endpoints for Immunotherapy Studies: Design and Regulatory Implications Axel Hoos
March 25, 2008 Molecular Diagnostics Affordability Through Sustainability – A New Approach to Technology Innovation Balu Balasubramanian
March 25, 2008 R&D Risk Mitigation Alliance Management: How Can Large and Small Companies Work Together? Teresa Faria
October 20, 2007 Fourth Annual Fall Oncology Conference Future Directions of Lung Cancer Giuseppe Giaccone
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.